Grade: Pharmaceutical Grade

Factory Location: Quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Dipeptidyl peptidase-4 (DPP-4) inhibitors delay the degradation of glucagon-like peptide-1 (GLP-1) by inhibiting DPP-4 enzyme, enhance insulin secretion and reduce glucagon release.

Indications:

Type 2 diabetes (single drug or in combination with metformin, sulfonylureas, etc.).

It is not suitable for type 1 diabetes or diabetic ketoacidosis.